Laboratory Corporation of America Holdings
NYSE:LH
Laboratory Corporation of America Holdings
Capital Expenditures
Laboratory Corporation of America Holdings
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Laboratory Corporation of America Holdings
NYSE:LH
|
Capital Expenditures
-$453.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
DaVita Inc
NYSE:DVA
|
Capital Expenditures
-$568m
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
|
Chemed Corp
NYSE:CHE
|
Capital Expenditures
-$56.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-7%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Capital Expenditures
-$408m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
CVS Health Corp
NYSE:CVS
|
Capital Expenditures
-$3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Cigna Corp
NYSE:CI
|
Capital Expenditures
-$1.6B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-12%
|
See Also
What is Laboratory Corporation of America Holdings's Capital Expenditures?
Capital Expenditures
-453.6m
USD
Based on the financial report for Dec 31, 2023, Laboratory Corporation of America Holdings's Capital Expenditures amounts to -453.6m USD.
What is Laboratory Corporation of America Holdings's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%
Over the last year, the Capital Expenditures growth was 6%. The average annual Capital Expenditures growth rates for Laboratory Corporation of America Holdings have been -6% over the past three years , -4% over the past five years , and -8% over the past ten years .